Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Elkins David V
Relationship:   Director
City:   Franklin Lakes
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   196,756    

Indirect Shares

   216      
Direct Value   $7,968,295    

Indirect Value

   $8,746      
Total Shares   196,972      
Total Value   $7,977,041      


Bristol-Myers Squibb Co $7,894,254 Tapestry Inc $74,041 Bristol-Myers Squibb Co $7,894,254 Tapestry Inc $74,041
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 5.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Becton Dickinson & Co BDX Executive VP and CFO 2012-11-09 0 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Bristol-Myers Squibb Co BMY EVP, Chief Financial O... 2024-03-10 194,968 2024-03-10 216    Premium*  
            Tapestry Inc TPR Director 2024-02-29 1,788 2024-02-29 0    Premium*  
* Premium Members only  

Records found :    52         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 8,792 88,800 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 D $55.41 $249,234 D/D (4,498) 84,302 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-31 4 D $62.35 $1,511,738 D/D (24,246) 107,457 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-31 4 OE $0.00 $0 D/D 47,401 131,703 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-01 4 D $68.63 $712,448 D/D (10,381) 121,653 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-01 4 OE $0.00 $0 D/D 24,577 132,034 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 D $68.42 $630,969 D/D (9,222) 130,460 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 A $0.00 $0 D/D 1,962 135,035 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 OE $0.00 $0 D/D 16,067 134,133 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-09-13 4 S $71.29 $9,551,167 D/D (133,951) 119,786 0 %
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-09-13 4 OE $48.49 $5,977,702 D/D 123,277 223,737 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 D $81.13 $364,923 D/D (4,498) 124,080 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 OE $0.00 $0 D/D 8,792 128,578 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 D $65.71 $2,715,860 D/D (41,331) 163,550 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 A $0.00 $0 D/D 8,930 191,187 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 OE $0.00 $0 D/D 71,871 185,308 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 OE $0.00 $0 D/D 8,792 172,342 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 D $50.10 $186,873 D/D (3,730) 168,612 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 D $53.79 $996,298 D/D (18,522) 194,968 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 D $0.00 $0 D/D (19,448) 208,313 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 OE $0.00 $0 D/D 64,326 225,111 0 -
CELG Celgene Corp EVP, CHIEF FINANCIAL OFFICER   •       –      –    2019-08-01 4 D $93.05 $1,027,179 D/D (11,039) 13,908 0 -
CELG Celgene Corp EVP, CHIEF FINANCIAL OFFICER   •       –      –    2019-08-01 4 OE $0.00 $0 D/D 24,947 24,947 0 -
CELG Celgene Corp EVP, CHIEF FINANCIAL OFFICER   •       –      –    2019-11-20 4 D $0.00 $0 I/I (195) 0 0 -
CELG Celgene Corp EVP, CHIEF FINANCIAL OFFICER   •       –      –    2019-11-20 4 D $0.00 $0 D/D (57,132) 0 0 -
  52  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us